Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.015599190366108606,6.355891719745223,26.4439180007473,"['SERPINH1', 'PLOD2', 'TMEM38B']",0.6766026788356688,0,0,3
2,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.01739501030409443,12.079818594104308,48.942253307442265,"['ALDH1A1', 'MTR']",0.6766026788356688,0,0,2
3,White fat cell differentiation WP4149,0.017526967411601993,6.052775250227479,24.47751141717952,"['RORA', 'KLF4', 'KLF2']",0.6766026788356688,0,0,3
4,NRF2 pathway WP2884,0.02020029741081206,2.9699394301951694,11.588875768697683,"['SLC6A9', 'FTH1', 'TXNRD1', 'GSR', 'SLC39A11', 'SLC5A3']",0.6766026788356688,0,0,6
5,15q13.3 copy number variation syndrome WP4942,0.02141351138527698,10.56904761904762,40.62459904649194,"['MTMR10', 'SERPINH1']",0.6766026788356688,0,0,2
6,Iron metabolism in placenta WP2007,0.02141351138527698,10.56904761904762,40.62459904649194,"['FTH1', 'ACO1']",0.6766026788356688,0,0,2
7,Amino Acid metabolism WP3925,0.023253719987300192,3.269230769230769,12.296525524036598,"['RARS', 'ALDH1A1', 'ODC1', 'GSR', 'FARSB']",0.6766026788356688,0,0,5
8,Dopaminergic Neurogenesis WP2855,0.025775340146120717,9.39400352733686,34.366431174625106,"['NR4A2', 'ALDH1A1']",0.6766026788356688,0,0,2
9,Nuclear Receptors Meta-Pathway WP2882,0.04537400930467792,1.9987317370129871,6.181709136452062,"['NCOA1', 'SLC6A9', 'CPT2', 'DNAJC7', 'FTH1', 'TXNRD1', 'GSR', 'SLC39A11', 'SLC5A3']",0.8237913492171612,0,0,9
10,Constitutive Androstane Receptor Pathway WP2875,0.046305112084552146,6.501587301587302,19.976145915394113,"['NCOA1', 'DNAJC7']",0.8237913492171612,0,0,2
11,Triacylglyceride synthesis WP325,0.052125920888360336,6.036734693877551,17.83307529212389,"['AGPAT3', 'PLPP1']",0.8237913492171612,0,0,2
12,Pregnane X receptor pathway WP2876,0.052125920888360336,6.036734693877551,17.83307529212389,"['NCOA1', 'DNAJC7']",0.8237913492171612,0,0,2
13,EV release from cardiac cells and their functional effects WP3297,0.06810846084168261,21.080696202531644,56.63653323606991,['KLF2'],0.8237913492171612,0,0,1
14,Fatty Acid Omega Oxidation WP206,0.06810846084168261,21.080696202531644,56.63653323606991,['ALDH1A1'],0.8237913492171612,0,0,1
15,Hypothetical Craniofacial Development Pathway WP3655,0.06810846084168261,21.080696202531644,56.63653323606991,['ARHGAP29'],0.8237913492171612,0,0,1
16,let-7 inhibition of ES cell reprogramming WP3299,0.06810846084168261,21.080696202531644,56.63653323606991,['KLF4'],0.8237913492171612,0,0,1
17,MED and Pseudoachondroplasia genes WP4789,0.06810846084168261,21.080696202531644,56.63653323606991,['COL9A2'],0.8237913492171612,0,0,1
18,Methionine De Novo and Salvage Pathway WP3580,0.07099830099972969,4.9703081232493,13.146958695688639,"['ODC1', 'MTR']",0.8237913492171612,0,0,2
19,Energy Metabolism WP1541,0.07767553212573323,3.1731687898089174,8.108128403757703,"['NCOA1', 'PPP3CB', 'NRF1']",0.8237913492171612,0,0,3
20,Phosphoinositides metabolism WP4971,0.08640420527180875,3.0216105550500454,7.399074971974508,"['MTMR10', 'INPP5D', 'PLCE1']",0.8237913492171612,0,0,3
21,Oxidative Stress WP408,0.09894675297923239,4.022373393801965,9.304447228846547,"['TXNRD1', 'GSR']",0.8237913492171612,0,0,2
22,Selenium Micronutrient Network WP15,0.10502529339571819,2.7580310163389643,6.215372017508355,"['TXNRD1', 'GSR', 'MTR']",0.8237913492171612,0,0,3
23,Kit receptor signaling pathway WP304,0.10990835164752373,2.6991462257758503,5.960007527669032,"['RPS6KA3', 'INPP5D', 'MAPT']",0.8237913492171612,0,0,3
24,Nucleotide GPCRs WP80,0.11092490115275942,10.53876582278481,23.17371190509468,['ADORA1'],0.8237913492171612,0,0,1
25,Ethanol effects on histone modifications WP3996,0.11389352485009659,3.672049689440994,7.977495855030022,"['ALDH1A1', 'MTR']",0.8237913492171612,0,0,2
26,Wnt signaling in kidney disease WP4150,0.12937097004009424,3.3777777777777778,6.907796272538291,"['FZD3', 'FZD9']",0.8237913492171612,0,0,2
27,Sulfation Biotransformation Reaction WP692,0.13159193760115373,8.430379746835444,17.097227652912984,['GSR'],0.8237913492171612,0,0,1
28,Nuclear receptors WP170,0.1372834787047664,3.2476190476190476,6.448820861349771,"['NR4A2', 'RORA']",0.8237913492171612,0,0,2
29,Regulation of Actin Cytoskeleton WP51,0.1402913862430618,1.873723621511232,3.680056316583966,"['CYFIP2', 'PPP1R12A', 'MRAS', 'MYL3', 'IQGAP1']",0.8237913492171612,0,0,5
30,Pathways affected in adenoid cystic carcinoma WP3651,0.14091938577009758,2.392500901333974,4.688266493749798,"['NFIB', 'ATRX', 'DTX4']",0.8237913492171612,0,0,3
31,Ketogenesis and Ketolysis WP4742,0.15178003922167446,7.024789029535865,13.243995741629504,['CPT2'],0.8237913492171612,0,0,1
32,Role of Osx and miRNAs in tooth development WP3971,0.15178003922167446,7.024789029535865,13.243995741629504,['KLF4'],0.8237913492171612,0,0,1
33,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.15184512969130157,2.3051534452808338,4.344970269588783,"['FZD3', 'FZD9', 'KLF4']",0.8237913492171612,0,0,3
34,Ciliopathies WP4803,0.15595043350826202,1.6945337620578778,3.148811538864612,"['NEK8', 'NME9', 'PKD1L1', 'BBIP1', 'TOPORS', 'GLIS2']",0.8237913492171612,0,0,6
35,MAPK Signaling Pathway WP382,0.16931983402215015,1.577882635552505,2.8022656659369627,"['RPS6KA3', 'PPP3CB', 'MRAS', 'DUSP1', 'MAPT', 'HSPA2', 'DUSP16']",0.8237913492171612,0,0,7
36,Adipogenesis WP236,0.17053474833884213,1.9005635926338085,3.36174767263544,"['NCOA1', 'GDF10', 'RORA', 'PLIN2']",0.8237913492171612,0,0,4
37,Valproic acid pathway WP3871,0.17150026985398392,6.020795660036167,10.615688926341443,['IVD'],0.8237913492171612,0,0,1
38,Heme Biosynthesis WP561,0.17150026985398392,6.020795660036167,10.615688926341443,['FECH'],0.8237913492171612,0,0,1
39,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.18662215583280348,2.6375,4.427490181823676,"['BST2', 'RPS6KA3']",0.8237913492171612,0,0,2
40,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.19076343874371923,5.267800632911392,8.727276770831397,['KLF4'],0.8237913492171612,0,0,1
41,Transcriptional cascade regulating adipogenesis WP4211,0.19076343874371923,5.267800632911392,8.727276770831397,['KLF2'],0.8237913492171612,0,0,1
42,Vitamin B12 Disorders WP4271,0.19076343874371923,5.267800632911392,8.727276770831397,['MTR'],0.8237913492171612,0,0,1
43,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.19076343874371923,5.267800632911392,8.727276770831397,['MTR'],0.8237913492171612,0,0,1
44,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.19507973910733883,2.5573833573833573,4.179651525178232,"['MAP4K5', 'TEAD1']",0.8237913492171612,0,0,2
45,TCA cycle in senescence WP5050,0.20958010634296373,4.682137834036568,7.316539144439764,['ME2'],0.8237913492171612,0,0,1
46,Trans-sulfuration pathway WP2333,0.20958010634296373,4.682137834036568,7.316539144439764,['MTR'],0.8237913492171612,0,0,1
47,Development and heterogeneity of the ILC family WP3893,0.20958010634296373,4.682137834036568,7.316539144439764,['RORA'],0.8237913492171612,0,0,1
48,Eicosanoid Synthesis WP167,0.20958010634296373,4.682137834036568,7.316539144439764,['TBXAS1'],0.8237913492171612,0,0,1
49,Mesodermal commitment pathway WP2857,0.22281258227970233,1.6900958466453675,2.5375509719542837,"['SESN1', 'KLF4', 'TEAD1', 'PARP8']",0.8237913492171612,0,0,4
50,Disorders of Folate Metabolism and Transport WP4259,0.22796058991004237,4.2136075949367084,6.230166520169253,['MTR'],0.8237913492171612,0,0,1
51,Glutathione metabolism WP100,0.22796058991004237,4.2136075949367084,6.230166520169253,['GSR'],0.8237913492171612,0,0,1
52,GPR40 Pathway WP3958,0.22796058991004237,4.2136075949367084,6.230166520169253,['PLCE1'],0.8237913492171612,0,0,1
53,Homologous recombination WP186,0.22796058991004237,4.2136075949367084,6.230166520169253,['RAD54B'],0.8237913492171612,0,0,1
54,miR-509-3p alteration of YAP1/ECM axis WP3967,0.22796058991004237,4.2136075949367084,6.230166520169253,['TEAD1'],0.8237913492171612,0,0,1
55,Glycogen Synthesis and Degradation WP500,0.22931618487996172,2.28022308022308,3.35797851753262,"['PYGB', 'PPP2R2B']",0.8237913492171612,0,0,2
56,Endochondral Ossification with Skeletal Dysplasias WP4808,0.23794525898082383,2.2200501253132834,3.1873584576723815,"['SERPINH1', 'SLC38A2']",0.8237913492171612,0,0,2
57,Endochondral Ossification WP474,0.23794525898082383,2.2200501253132834,3.1873584576723815,"['SERPINH1', 'SLC38A2']",0.8237913492171612,0,0,2
58,Cell Differentiation - Index expanded WP2023,0.24591496915863958,3.830264672036824,5.372978292736421,['KLF4'],0.8237913492171612,0,0,1
59,ATM Signaling Network in Development and Disease  WP3878,0.24659063236443507,2.162962962962963,3.02820368469052,"['PPM1D', 'HMGN1']",0.8237913492171612,0,0,2
60,Pathways in clear cell renal cell carcinoma WP4018,0.24682909684466117,1.7835292006817978,2.495262753776065,"['PLOD2', 'SDSL', 'PFKP']",0.8237913492171612,0,0,3
61,Eukaryotic Transcription Initiation WP405,0.2552469071460822,2.108730158730159,2.87952151257466,"['POLR1A', 'GTF2H3']",0.8237913492171612,0,0,2
62,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.2634530915339819,3.51081223628692,4.683002041744435,['UNC13D'],0.8237913492171612,0,0,1
63,Omega-9 FA synthesis WP4724,0.2634530915339819,3.51081223628692,4.683002041744435,['ELOVL6'],0.8237913492171612,0,0,1
64,PPAR-alpha pathway WP2878,0.2634530915339819,3.51081223628692,4.683002041744435,['CPT2'],0.8237913492171612,0,0,1
65,Exercise-induced Circadian Regulation WP410,0.26390892599934856,2.057142857142857,2.7404253516946926,"['CRY2', 'ERC2']",0.8237913492171612,0,0,2
66,One-carbon metabolism and related pathways WP3940,0.26390892599934856,2.057142857142857,2.7404253516946926,"['GSR', 'MTR']",0.8237913492171612,0,0,2
67,Wnt signaling pathway and pluripotency WP399,0.26564193550456444,1.710836632811155,2.2678952783441675,"['FZD3', 'PPP2R2B', 'FZD9']",0.8237913492171612,0,0,3
68,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.28058457772312867,3.240506329113924,4.118294925315992,['NRF1'],0.8237913492171612,0,0,1
69,Cori Cycle WP1946,0.28058457772312867,3.240506329113924,4.118294925315992,['PFKP'],0.8237913492171612,0,0,1
70,Cysteine and methionine catabolism WP4504,0.28058457772312867,3.240506329113924,4.118294925315992,['MTR'],0.8237913492171612,0,0,1
71,Genotoxicity pathway WP4286,0.281230720271255,1.9611664820967147,2.4878963365171494,"['PPM1D', 'TOPORS']",0.8237913492171612,0,0,2
72,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.2973188266917855,3.0088155515370705,3.6495435014649993,['ACO1'],0.8237913492171612,0,0,1
73,MAPK pathway in congenital thyroid cancer WP4928,0.2973188266917855,3.0088155515370705,3.6495435014649993,['ALK'],0.8237913492171612,0,0,1
74,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.2973188266917855,3.0088155515370705,3.6495435014649993,['LPP'],0.8237913492171612,0,0,1
75,Mitochondrial complex III assembly WP4921,0.2973188266917855,3.0088155515370705,3.6495435014649993,['UQCRC2'],0.8237913492171612,0,0,1
76,Transcription co-factors SKI and SKIL protein partners WP4533,0.3136650208621989,2.808016877637131,3.2556980960135617,['TEAD1'],0.8237913492171612,0,0,1
77,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.3136650208621989,2.808016877637131,3.2556980960135617,['TBXAS1'],0.8237913492171612,0,0,1
78,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.3136650208621989,2.808016877637131,3.2556980960135617,['EIF3E'],0.8237913492171612,0,0,1
79,Wnt signaling WP428,0.32284615155579444,1.5242882357455299,1.7233288488219756,"['FZD3', 'PPP3CB', 'FZD9']",0.8237913492171612,0,0,3
80,Urea cycle and metabolism of amino groups WP497,0.32963213110520706,2.6323180379746836,2.921288648992336,['ODC1'],0.8237913492171612,0,0,1
81,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.32963213110520706,2.6323180379746836,2.921288648992336,['CPT2'],0.8237913492171612,0,0,1
82,p53 transcriptional gene network WP4963,0.33286608749395896,1.7202461937155815,1.8922966331900077,"['SESN1', 'FANCC']",0.8237913492171612,0,0,2
83,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.3413835416843449,1.6857142857142857,1.811719200208546,"['PLCE1', 'IFI44L']",0.8237913492171612,0,0,2
84,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.3452289215448991,2.47728965003723,2.6347153163521537,['MRAS'],0.8237913492171612,0,0,1
85,Purinergic signaling WP4900,0.3452289215448991,2.47728965003723,2.6347153163521537,['ADORA1'],0.8237913492171612,0,0,1
86,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.34986670928830976,1.652536570183629,1.7354989092891944,"['PLCE1', 'TLN1']",0.8237913492171612,0,0,2
87,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.3583125889085284,1.6206349206349207,1.6633378731843578,"['FZD3', 'FZD9']",0.8237913492171612,0,0,2
88,Vitamin D in inflammatory diseases WP4482,0.3604639542603408,2.3394866385372715,2.3871263429217717,['DUSP1'],0.8237913492171612,0,0,1
89,Hippo-Yap signaling pathway WP4537,0.3604639542603408,2.3394866385372715,2.3871263429217717,['TEAD1'],0.8237913492171612,0,0,1
90,Mitochondrial Gene Expression WP391,0.3604639542603408,2.3394866385372715,2.3871263429217717,['NRF1'],0.8237913492171612,0,0,1
91,Thermogenesis WP4321,0.3610990884394094,1.420883131754097,1.4473156431875498,"['RPS6KA3', 'CPT2', 'CREB5']",0.8237913492171612,0,0,3
92,Sleep regulation WP3591,0.3753455940759819,2.216189207195203,2.171661740208814,['ADORA1'],0.8237913492171612,0,0,1
93,Striated Muscle Contraction Pathway WP383,0.3753455940759819,2.216189207195203,2.171661740208814,['MYL3'],0.8237913492171612,0,0,1
94,Differentiation Pathway WP2848,0.3898820129308182,2.1052215189873418,1.9829315515908397,['ALK'],0.8237913492171612,0,0,1
95,TLR4 Signaling and Tolerance WP3851,0.4040811943744862,2.0048221820373717,1.8166484594342676,['INPP5D'],0.8237913492171612,0,0,1
96,Fluoropyrimidine Activity WP1601,0.4040811943744862,2.0048221820373717,1.8166484594342676,['UPP2'],0.8237913492171612,0,0,1
97,Endoderm differentiation WP2853,0.405286321914035,1.3165804140127388,1.1890847336521235,"['SESN1', 'LRPPRC', 'PARP8']",0.8237913492171612,0,0,3
98,Physiological and pathological hypertrophy of the heart WP1528,0.4179509380198456,1.9135500575373994,1.669364281672642,['PPP3CB'],0.8237913492171612,0,0,1
99,Pre-implantation embryo WP3527,0.4179509380198456,1.9135500575373994,1.669364281672642,['KLF4'],0.8237913492171612,0,0,1
100,Prostaglandin Synthesis and Regulation WP98,0.4179509380198456,1.9135500575373994,1.669364281672642,['TBXAS1'],0.8237913492171612,0,0,1
101,EGF/EGFR signaling pathway WP437,0.42589786403119406,1.212310662651987,1.0347746971947116,"['RPS6KA3', 'INPP5D', 'PLCE1', 'IQGAP1']",0.8237913492171612,0,0,4
102,Sphingolipid pathway WP1422,0.43149886352303735,1.8302146395156853,1.5382778385597464,['PLPP1'],0.8237913492171612,0,0,1
103,Aryl Hydrocarbon Receptor Pathway WP2873,0.43149886352303735,1.8302146395156853,1.5382778385597464,['NCOA1'],0.8237913492171612,0,0,1
104,Tryptophan metabolism WP465,0.43149886352303735,1.8302146395156853,1.5382778385597464,['ALDH1A1'],0.8237913492171612,0,0,1
105,TYROBP causal network in microglia WP3945,0.43149886352303735,1.8302146395156853,1.5382778385597464,['ADAP2'],0.8237913492171612,0,0,1
106,Focal Adhesion WP306,0.4362934720695001,1.1949334964765594,0.9911258316865103,"['VASP', 'PPP1R12A', 'PARVB', 'TLN1']",0.8237913492171612,0,0,4
107,"GPCRs, Class A Rhodopsin-like WP455",0.4401655946190171,1.3582181259600614,1.114559595744557,"['GPR35', 'ADORA1']",0.8237913492171612,0,0,2
108,Neural Crest Differentiation WP2064,0.4401655946190171,1.3582181259600614,1.114559595744557,"['PRTG', 'FZD3']",0.8237913492171612,0,0,2
109,Vitamin B12 metabolism WP1533,0.44473241489724963,1.7538238396624473,1.4210927522353398,['MTR'],0.8237913492171612,0,0,1
110,Resistin as a regulator of inflammation WP4481,0.44473241489724963,1.7538238396624473,1.4210927522353398,['PLCE1'],0.8237913492171612,0,0,1
111,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.45586051420254975,1.315575396825397,1.0334744676783563,"['FZD3', 'FZD9']",0.8237913492171612,0,0,2
112,Vitamin A and carotenoid metabolism WP716,0.4576588645150565,1.6835443037974684,1.3159107707615076,['ALDH1A1'],0.8237913492171612,0,0,1
113,Nanoparticle-mediated activation of receptor signaling WP2643,0.4576588645150565,1.6835443037974684,1.3159107707615076,['TLN1'],0.8237913492171612,0,0,1
114,One-carbon metabolism WP241,0.4576588645150565,1.6835443037974684,1.3159107707615076,['MTR'],0.8237913492171612,0,0,1
115,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4576588645150565,1.6835443037974684,1.3159107707615076,['TEAD1'],0.8237913492171612,0,0,1
116,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.4576588645150565,1.6835443037974684,1.3159107707615076,['CREB5'],0.8237913492171612,0,0,1
117,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.46067961279999914,1.202911737943585,0.9323197024721575,"['FZD3', 'PDCD6', 'FZD9']",0.8237913492171612,0,0,3
118,Melatonin metabolism and effects WP3298,0.4702853170466171,1.6186708860759493,1.2211507472595313,['CRY2'],0.8237913492171612,0,0,1
119,Alzheimer's disease WP2059,0.4712999385172459,1.2755170755170755,0.9595212092962077,"['PPP3CB', 'MAPT']",0.8237913492171612,0,0,2
120,DNA Repair Pathways Full Network WP4946,0.47269753697574635,1.1802488243347817,0.8843599150165911,"['FANCC', 'GTF2H3', 'RAD54B']",0.8237913492171612,0,0,3
121,Trans-sulfuration and one-carbon metabolism WP2525,0.48261871323438826,1.5586029067041725,1.135486404976818,['MTR'],0.8237913492171612,0,0,1
122,Zinc homeostasis WP3529,0.4946658338125366,1.5028254972875226,1.057798032152697,['SLC39A11'],0.8237913492171612,0,0,1
123,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.4963589211693449,1.1373730418316406,0.7966797515561174,"['RPS6KA3', 'MAP4K5', 'RHOQ']",0.8237913492171612,0,0,3
124,Breast cancer pathway WP4262,0.4963589211693449,1.1373730418316406,0.7966797515561174,"['NCOA1', 'FZD3', 'FZD9']",0.8237913492171612,0,0,3
125,ATM Signaling Pathway WP2516,0.5064333031353774,1.4508948057616762,0.9871346288678823,['AP3B2'],0.8237913492171612,0,0,1
126,Fatty acid beta-oxidation WP143,0.5064333031353774,1.4508948057616762,0.9871346288678823,['CPT2'],0.8237913492171612,0,0,1
127,Ciliary landscape WP4352,0.5154365196218064,1.057048060816905,0.7005492225075071,"['NEK8', 'ARMC8', 'IQGAP1', 'BBIP1', 'LRPPRC']",0.8237913492171612,0,0,5
128,Type 2 papillary renal cell carcinoma WP4241,0.5179275926502364,1.4024261603375527,0.9226839796247625,['COL21A1'],0.8237913492171612,0,0,1
129,Vitamin D-sensitive calcium signaling in depression WP4698,0.5179275926502364,1.4024261603375527,0.9226839796247625,['GSR'],0.8237913492171612,0,0,1
130,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5179275926502364,1.4024261603375527,0.9226839796247625,['PPP3CB'],0.8237913492171612,0,0,1
131,Amyotrophic lateral sclerosis (ALS) WP2447,0.5291550246296959,1.3570845242956309,0.8637487954316345,['PPP3CB'],0.8237913492171612,0,0,1
132,IL-5 signaling pathway WP127,0.5291550246296959,1.3570845242956309,0.8637487954316345,['MAPT'],0.8237913492171612,0,0,1
133,p38 MAPK Signaling Pathway WP400,0.5291550246296959,1.3570845242956309,0.8637487954316345,['HMGN1'],0.8237913492171612,0,0,1
134,Disruption of postsynaptic signaling by CNV WP4875,0.5401217754286401,1.3145767405063291,0.8097275498597003,['DLGAP1'],0.8237913492171612,0,0,1
135,Glycolysis and Gluconeogenesis WP534,0.5401217754286401,1.3145767405063291,0.8097275498597003,['PFKP'],0.8237913492171612,0,0,1
136,Target Of Rapamycin (TOR) Signaling WP1471,0.5508338787465044,1.2746451860375911,0.7600989739764177,['RRAGD'],0.8237913492171612,0,0,1
137,IL-2 signaling pathway WP49,0.5508338787465044,1.2746451860375911,0.7600989739764177,['MAPT'],0.8237913492171612,0,0,1
138,Androgen receptor signaling pathway WP138,0.5512846334047137,1.0923933209647496,0.6505246218734673,"['NCOA1', 'PLPP1']",0.8237913492171612,0,0,2
139,Integrin-mediated Cell Adhesion WP185,0.5512846334047137,1.0923933209647496,0.6505246218734673,"['VASP', 'TLN1']",0.8237913492171612,0,0,2
140,Hippo-Merlin Signaling Dysregulation WP4541,0.558122201389382,1.0783068783068783,0.6288441387975124,"['PPP1R12A', 'TEAD1']",0.8237913492171612,0,0,2
141,Ferroptosis WP4313,0.5612972293023647,1.2370625465376024,0.7144094264834191,['FTH1'],0.8237913492171612,0,0,1
142,G13 Signaling Pathway WP524,0.5612972293023647,1.2370625465376024,0.7144094264834191,['IQGAP1'],0.8237913492171612,0,0,1
143,Nephrotic syndrome WP4758,0.5612972293023647,1.2370625465376024,0.7144094264834191,['PLCE1'],0.8237913492171612,0,0,1
144,Osteoblast differentiation WP4787,0.5648854966060535,1.0645770544504722,0.608014266315023,"['FZD3', 'FZD9']",0.8237913492171612,0,0,2
145,IL-6 signaling pathway WP364,0.5715175857315065,1.201627486437613,0.6722625436474822,['NCOA1'],0.8277151241628714,0,0,1
146,Regulation of toll-like receptor signaling pathway WP1449,0.5781883192468016,1.0381344307270233,0.5687478149208854,"['RNF31', 'SFTPD']",0.8300198888493716,0,0,2
147,Folate Metabolism WP176,0.5815005736165827,1.168161040787623,0.6333107056258911,['MTR'],0.8300198888493716,0,0,1
148,IL-3 signaling pathway WP286,0.5912516888985649,1.1365035921997948,0.5972479608288997,['INPP5D'],0.8300198888493716,0,0,1
149,Notch Signaling WP268,0.5912516888985649,1.1365035921997948,0.5972479608288997,['DTX4'],0.8300198888493716,0,0,1
150,ESC Pluripotency Pathways WP3931,0.597580879906204,1.0008314436885866,0.5152937222648214,"['FZD3', 'FZD9']",0.8300198888493716,0,0,2
151,Netrin-UNC5B signaling pathway WP4747,0.6007763005004976,1.106512325116589,0.5638041305859686,['INPP5D'],0.8300198888493716,0,0,1
152,Regulation of Microtubule Cytoskeleton WP2038,0.6007763005004976,1.106512325116589,0.5638041305859686,['MAPT'],0.8300198888493716,0,0,1
153,7q11.23 copy number variation syndrome WP4932,0.6162982828713921,0.966101076445904,0.46761630760889805,"['FZD9', 'HSPA2']",0.8432348051489074,0,0,2
154,Histone Modifications WP2369,0.6191668718992233,1.0510284810126582,0.5038425162727775,['SETBP1'],0.8432348051489074,0,0,1
155,Metapathway biotransformation Phase I and II WP702,0.6223875942765745,0.955050505050505,0.45287753676684495,"['GSR', 'NAT10']",0.8432348051489074,0,0,2
156,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.636712812132658,1.0008288125376732,0.4518107257353106,['PPP1R12A'],0.8571134009478089,0,0,1
157,Nucleotide Excision Repair WP4753,0.645181201247685,0.9774801295260523,0.4283553201903546,['GTF2H3'],0.8571889245648572,0,0,1
158,Circadian rhythm related genes WP3594,0.6496229811193365,0.8997952684258417,0.38813848843015225,"['CRY2', 'ADORA1', 'RORA']",0.8571889245648572,0,0,3
159,Insulin Signaling WP481,0.6496229811193365,0.8997952684258417,0.38813848843015225,"['RPS6KA3', 'MAP4K5', 'RHOQ']",0.8571889245648572,0,0,3
160,PPAR signaling pathway WP3942,0.6534527956713321,0.955192750287687,0.406420169803016,['CPT2'],0.8571889245648572,0,0,1
161,IL-4 signaling pathway WP395,0.6615321545240098,0.9338959212376934,0.38588270169165567,['INPP5D'],0.8571889245648572,0,0,1
162,Ebola Virus Pathway on Host WP4217,0.6629327388454168,0.8842105263157894,0.36348280490972,"['BST2', 'IQGAP1']",0.8571889245648572,0,0,2
163,Copper homeostasis WP3286,0.6694237315649361,0.91352504127683,0.36663234849644183,['MAPT'],0.8571889245648572,0,0,1
164,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.6694237315649361,0.91352504127683,0.36663234849644183,['DDX17'],0.8571889245648572,0,0,1
165,Rett syndrome causing genes WP4312,0.6771318778337637,0.8940210072717479,0.3485691600274547,['KCNJ10'],0.8618042081520629,0,0,1
166,Translation Factors WP107,0.6846608438033399,0.875329641350211,0.3316026002205958,['EIF3E'],0.8650184770456476,0,0,1
167,DNA damage response WP707,0.6920147816365181,0.8574011883234306,0.3156505008231748,['SESN1'],0.8650184770456476,0,0,1
168,Mitochondrial complex I assembly model OXPHOS system WP4324,0.6920147816365181,0.8574011883234306,0.3156505008231748,['NDUFAF2'],0.8650184770456476,0,0,1
169,IL-1 signaling pathway WP195,0.7062137047861472,0.8236535120377265,0.2864974873111203,['HSPB2'],0.867279988333865,0,0,1
170,miRNA regulation of DNA damage response WP1530,0.7062137047861472,0.8236535120377265,0.2864974873111203,['SESN1'],0.867279988333865,0,0,1
171,Notch Signaling Pathway Netpath WP61,0.7062137047861472,0.8236535120377265,0.2864974873111203,['MAPT'],0.867279988333865,0,0,1
172,3q29 copy number variation syndrome WP4906,0.726297786705428,0.7777191748710736,0.24871083864146154,['PIGM'],0.881633151492138,0,0,1
173,MET in type 1 papillary renal cell carcinoma WP4205,0.726297786705428,0.7777191748710736,0.24871083864146154,['ALK'],0.881633151492138,0,0,1
174,AMP-activated protein kinase (AMPK) signaling WP1403,0.7389207529971422,0.7498304701627486,0.2268721557036704,['SLC2A4RG'],0.8918009087896543,0,0,1
175,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.745012888301984,0.7366200310903842,0.2168268765926577,['HSPA2'],0.8940154659623808,0,0,1
176,VEGFA-VEGFR2 Signaling Pathway WP3888,0.7633484949000058,0.8040322580645162,0.21712136061116302,"['NR4A2', 'MOV10', 'TFCP2', 'PDE4DIP', 'LARP7', 'IQGAP1', 'FARSB']",0.8977605337750134,0,0,7
177,Head and Neck Squamous Cell Carcinoma WP4674,0.7679967217941218,0.6881095663000623,0.18164015446236423,['SESN1'],0.8977605337750134,0,0,1
178,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.7838685151725667,0.6557060917721519,0.1596736020426626,['SEC31A'],0.8977605337750134,0,0,1
179,Non-small cell lung cancer WP4255,0.7838685151725667,0.6557060917721519,0.1596736020426626,['ALK'],0.8977605337750134,0,0,1
180,16p11.2 proximal deletion syndrome WP4949,0.7889147838419646,0.6455696202531646,0.15306260039496458,['PPP4R4'],0.8977605337750134,0,0,1
181,DNA IR-damage and cellular response via ATR WP4016,0.7889147838419646,0.6455696202531646,0.15306260039496458,['PPM1D'],0.8977605337750134,0,0,1
182,Retinoblastoma gene in cancer WP2446,0.7889147838419646,0.6455696202531646,0.15306260039496458,['HMGB2'],0.8977605337750134,0,0,1
183,Leptin signaling pathway WP2034,0.7938435934684324,0.6357403145377829,0.14677261795729976,['NCOA1'],0.8977605337750134,0,0,1
184,Integrated breast cancer pathway WP1984,0.8018989847400847,0.6651045603426555,0.14683688516540921,"['RASGEF1A', 'ODC1']",0.8977605337750134,0,0,2
185,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8033596746350847,0.6169489947877885,0.13508268006791907,['MAP4K5'],0.8977605337750134,0,0,1
186,Corticotropin-releasing hormone signaling pathway WP2355,0.8079522097784829,0.6079618418638781,0.12964930274969322,['NR4A2'],0.8977605337750134,0,0,1
187,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8079522097784829,0.6079618418638781,0.12964930274969322,['PPP3CB'],0.8977605337750134,0,0,1
188,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8088347425035363,0.6546130952380952,0.13888314409211389,"['RPS6KA3', 'MAPT']",0.8977605337750134,0,0,2
189,B Cell Receptor Signaling Pathway WP23,0.8124378155068649,0.5992314647377939,0.12446990448520866,['INPP5D'],0.8977605337750134,0,0,1
190,Joubert Syndrome WP4656,0.8124378155068649,0.5992314647377939,0.12446990448520866,['NEK8'],0.8977605337750134,0,0,1
191,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8210981095133231,0.5824982419127989,0.11481778760912129,['MRAS'],0.8977605337750134,0,0,1
192,Pathways Regulating Hippo Signaling WP4540,0.8252775907011031,0.5744754638460204,0.11031966895748505,['TEAD1'],0.8977605337750134,0,0,1
193,Pyrimidine metabolism WP4022,0.8252775907011031,0.5744754638460204,0.11031966895748505,['POLR1A'],0.8977605337750134,0,0,1
194,Spinal Cord Injury WP2431,0.8293597312016792,0.5666695176188847,0.10602459439018491,['VCAN'],0.8977605337750134,0,0,1
195,Vitamin D Receptor Pathway WP2877,0.8372409777545832,0.5516738840772818,0.09800119324110428,['KLF4'],0.9016441298895511,0,0,1
196,Ras signaling WP4223,0.8460808732929581,0.5979591836734693,0.09994309470921105,"['MRAS', 'PLCE1']",0.9065152213853123,0,0,2
197,22q11.2 copy number variation syndrome WP4657,0.8519313868133129,0.5239319620253164,0.08395972351083938,['XPO1'],0.9081502092933793,0,0,1
198,Male infertility WP4673,0.8620748545180777,0.5048802806161354,0.07493088488608436,['MTR'],0.908837837139149,0,0,1
199,Cytoplasmic Ribosomal Proteins WP477,0.8684492696244944,0.49292628443782577,0.06952533320796528,['RPS6KA3'],0.908837837139149,0,0,1
200,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.8684492696244944,0.49292628443782577,0.06952533320796528,['UQCRC2'],0.908837837139149,0,0,1
201,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8698876441188998,0.605464783531801,0.08439647506411718,"['CAB39L', 'PPP2R2B', 'CREB5']",0.908837837139149,0,0,3
202,PI3K-Akt signaling pathway WP4172,0.8779866873486485,0.5938056570169348,0.07726827701663658,"['PPP2R2B', 'COL9A2', 'CREB5']",0.9127584373426544,0,0,3
203,Gastrin signaling pathway WP4659,0.8885337023978286,0.4551802421574023,0.053794430147790846,['KLF4'],0.9191727955839607,0,0,1
204,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9254834031531417,0.38369527348739985,0.029713008968889426,['RORA'],0.9458872533301502,0,0,1
205,IL-18 signaling pathway WP4754,0.9302065300491684,0.45850340136054424,0.03317209851794718,"['PYGB', 'KLF2']",0.9458872533301502,0,0,2
206,Calcium Regulation in the Cardiac Cell WP536,0.9338130016278335,0.36672773706417944,0.025113175546623397,['ATP1B3'],0.9458872533301502,0,0,1
207,Fragile X Syndrome  WP4549,0.93536402033498,0.36351128233351676,0.024289641729983786,['CYFIP2'],0.9458872533301502,0,0,1
208,Ectoderm Differentiation WP2858,0.9368788032984345,0.36035028371890004,0.02349532517872945,['HMGB2'],0.9458872533301502,0,0,1
209,Hepatitis B infection WP4666,0.9425921652261814,0.3482331223628692,0.020588091149664825,['CREB5'],0.9471021755861152,0,0,1
210,Nonalcoholic fatty liver disease WP4396,0.9536320858176758,0.32371700520066726,0.01536922108851805,['UQCRC2'],0.9536320858176758,0,0,1
